Download PDF
CC BY-NC-ND 4.0 · J Neurol Surg Rep 2023; 84(04): e144-e145
DOI: 10.1055/a-2192-5775
Skull Base Oncology Case Series

Proton Therapy for Skull Base Chondrosarcoma

Dennis M. Tang
1   Department of Otolaryngology, Cedars-Sinai Medical Center, Los Angeles, California, United States
,
Raffaello M. Cutri
1   Department of Otolaryngology, Cedars-Sinai Medical Center, Los Angeles, California, United States
,
Arthur W. Wu
1   Department of Otolaryngology, Cedars-Sinai Medical Center, Los Angeles, California, United States
,
Chirag Patil
2   Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, United States
,
Zachary S. Zumsteg
3   Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Chondrosarcoma is a type of an endochondral bone malignancy that is primarily treated surgically with radiation therapy used in the adjuvant setting or in cases of unresectable disease. Proton therapy has potential advantages compared with traditional photon therapy for the treatment of tumors in close proximity to critical structures due to the theoretic lower exit dose. Studies have shown improved survival in patients with skull base chondrosarcoma who undergo proton therapy. However, there is a lack of randomized data. Further studies are needed to define the role of proton therapy in the treatment of skull base chondrosarcoma.

Keywords

skull base - chondrosarcoma - radiation therapy - proton therapy


Publication History

Received: 27 September 2023

Accepted: 06 October 2023

Accepted Manuscript online:
16 October 2023

Article published online:
20 November 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Noel G, Gondi V. Proton therapy for tumors of the base of the skull. Chin Clin Oncol 2016; 5 (04) 51
    CrossrefPubMedGoogle Scholar
  • 2 Amichetti M, Amelio D, Cianchetti M, Enrici RM, Minniti G. A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base. Neurosurg Rev 2010; 33 (02) 155-165
    CrossrefPubMedGoogle Scholar
  • 3 Simon F, Feuvret L, Bresson D. et al. Surgery and proton therapy in Grade I and II skull base chondrosarcoma: a comparative retrospective study. PLoS One 2018; 13 (12) e0208786
    CrossrefPubMedGoogle Scholar
  • 4 Hasegawa H, Vakharia K, Graffeo CS. et al. Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy. J Neurooncol 2021; 153 (02) 273-281
    CrossrefPubMedGoogle Scholar
  • 5 Palmisciano P, Haider AS, Sabahi M. et al. Primary skull base chondrosarcomas: a systematic review. Cancers (Basel) 2021; 13 (23) 5960
    CrossrefPubMedGoogle Scholar
  • 6 Crockard HA, Cheeseman A, Steel T. et al. A multidisciplinary team approach to skull base chondrosarcomas. J Neurosurg 2001; 95 (02) 184-189
    CrossrefPubMedGoogle Scholar
  • 7 Bohman LE, Koch M, Bailey RL, Alonso-Basanta M, Lee JY. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. World Neurosurg 2014; 82 (05) 806-814
    CrossrefPubMedGoogle Scholar
  • 8 Chow WA. Update on chondrosarcomas. Curr Opin Oncol 2007; 19 (04) 371-376
    CrossrefPubMedGoogle Scholar
  • 9 Gelderblom H, Hogendoorn PC, Dijkstra SD. et al. The clinical approach towards chondrosarcoma. Oncologist 2008; 13 (03) 320-329 DOI: 10.1634/theoncologist.2007-0237. Erratum in: Oncologist. 2008 May;13(5):618. PMID: 18378543
    CrossrefPubMedGoogle Scholar
  • 10 Nguyen QN, Chang EL. Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep 2008; 10 (04) 338-343
    CrossrefPubMedGoogle Scholar
  • 11 St Clair WH, Adams JA, Bues M. et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004; 58 (03) 727-734
    CrossrefPubMedGoogle Scholar
  • 12 Dabaja BS, Hoppe BS, Plastaras JP. et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood 2018; 132 (16) 1635-1646
    CrossrefPubMedGoogle Scholar
  • 13 MacDonald SM, Trofimov A, Safai S. et al. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys 2011; 79 (01) 121-129
    CrossrefPubMedGoogle Scholar
  • 14 Rosenberg AE, Nielsen GP, Keel SB. et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999; 23 (11) 1370-1378
    CrossrefPubMedGoogle Scholar
  • 15 Hug EB, Loredo LN, Slater JD. et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91 (03) 432-439
    CrossrefPubMedGoogle Scholar
  • 16 Weber DC, Badiyan S, Malyapa R. et al. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. Neuro-oncol 2016; 18 (02) 236-243
    CrossrefPubMedGoogle Scholar
  • 17 Feuvret L, Bracci S, Calugaru V. et al. Efficacy and safety of adjuvant proton therapy combined with surgery for chondrosarcoma of the skull base: a retrospective, population-based study. Int J Radiat Oncol Biol Phys 2016; 95 (01) 312-321
    CrossrefPubMedGoogle Scholar
  • 18 Rimmer RA, Mace JC, Andersen PE. et al. Determinants of survival in sinonasal and skull base chondrosarcoma: an analysis of the National Cancer Database. Int Forum Allergy Rhinol 2022; 12 (05) 699-713
    CrossrefPubMedGoogle Scholar
  • 19 Patel SH, Wang Z, Wong WW. et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol 2014; 15 (09) 1027-1038
    CrossrefPubMedGoogle Scholar
  • 20 Li PC, Liebsch NJ, Niemierko A. et al. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy. Radiother Oncol 2019; 131: 112-119
    CrossrefPubMedGoogle Scholar
  • 21 De Leo AN, Holtzman AL, Ho MW. et al. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma. Radiother Oncol 2021; 158: 125-130
    CrossrefPubMedGoogle Scholar